IMVT · Immunovant, Inc.
$39.14
+0.24 (+0.62%)
At close · Jul 29
Market Cap
$7.99B
Shares
205.31M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-11-09 | $150,000,000 | — | — | — | 10-Q , filed 2026-02-06 |
Key facts
CIK
1764013
CUSIP
45258J102
13F (30d)
28 filings
28 filers
Visit website
Investor relations